Overview

A Randomized, Open Label, Three-Treatment, Three-Period, Six-Sequence Crossover Study To Compare Safety and Pharmacokinetic Properties of CJ-30044 and Bepotastine Besilate and To Investigate Food-effect on Pharmacokinetics of CJ-30044 in Healthy Adu

Status:
Completed
Trial end date:
2013-05-01
Target enrollment:
Participant gender:
Summary
Study objectives - To compare the safety and pharmacokinetic properties of CJ-30044 and bepotastine besylate after a single oral administration in healthy male volunteers. - To evaluate the food-effect on pharmacokinetics of CJ-30044 after a single oral administration in healthy male volunteers.
Phase:
Phase 1
Details
Lead Sponsor:
CJ HealthCare Corporation
HK inno.N Corporation